CUE · Categories · Form 4

CUE - SEC Form 4 insider transactions

Cue Biopharma Inc. (CUE) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CUE

• 20h
  SEC Form 4 filed by Director Meehan Viola Mong

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 27d
  CHIEF EXECUTIVE OFFICER Lin Shao-Lee was granted 327,537 shares (SEC Form 4)

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 54d
  SEC Form 4 filed by Warren Lucinda

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 54d
  SEC Form 4 filed by Sandercock Colin

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 54d
  SEC Form 4 filed by Baker Daniel G.

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 148d
  SEC Form 4 filed by Director Broadfoot Jill Marie

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 148d
  SEC Form 4 filed by Director Garzone Pamela

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 148d
  SEC Form 4 filed by Director Kiener Peter A

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 148d
  SEC Form 4 filed by Director Sarraf Pasha

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 148d
  SEC Form 4 filed by Director Verheyen Patrick

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 148d
  SEC Form 4 filed by Director Morich Frank

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 179d
  SEC Form 4 filed by SVP, GENERAL COUNSEL Sandercock Colin

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 190d
  SEC Form 4 filed by CHIEF DEVELOPMENT OFFICER Baker Daniel G.

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 190d
  SEC Form 4 filed by CHIEF BUSINESS OFFICER Warren Lucinda

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 243d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Azam Usman

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 362d
  SEC Form 4 filed by Director Broadfoot Jill Marie

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 435d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER Millar Kerri-Ann

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 435d
  SEC Form 4 filed by CHIEF DEVELOPMENT OFFICER Baker Daniel G.

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 435d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Passeri Daniel R

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 435d
  SEC Form 4 filed by SVP, GENERAL COUNSEL Sandercock Colin

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 435d
  SEC Form 4 filed by CHIEF BUSINESS OFFICER Warren Lucinda

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 435d
  SEC Form 4 filed by Chief Medical Officer Levisetti Matteo

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 448d
  SEC Form 4 filed by Director Sarraf Pasha

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 516d
  SEC Form 4 filed by Director Morich Frank

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 516d
  SEC Form 4 filed by Director Kiener Peter A

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 516d
  SEC Form 4 filed by Director Verheyen Patrick

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 516d
  SEC Form 4 filed by Director Driscoll Frederick W

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 516d
  SEC Form 4 filed by Director Garzone Pamela

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 551d
  SEC Form 4 filed by CHIEF DEVELOPMENT OFFICER Baker Daniel G.

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 636d
  SEC Form 4 filed by CHIEF BUSINESS OFFICER Warren Lucinda

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 726d
  SEC Form 4 filed by Fox Michael J

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 726d
  SEC Form 4 filed by Levisetti Matteo

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 726d
  SEC Form 4 filed by Suri Anish

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 726d
  SEC Form 4 filed by Sandercock Colin

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 726d
  SEC Form 4 filed by Millar Kerri-Ann

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 817d
  SEC Form 4 filed by Millar Kerri-Ann

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 817d
  SEC Form 4 filed by Suri Anish

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 817d
  SEC Form 4 filed by Sandercock Colin

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 817d
  SEC Form 4 filed by Levisetti Matteo

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 817d
  SEC Form 4 filed by Passeri Daniel R

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 832d
  SEC Form 4 filed by Levisetti Matteo

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 881d
  SEC Form 4 filed by Garzone Pamela

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 881d
  SEC Form 4 filed by Kiener Peter A

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 881d
  SEC Form 4 filed by Driscoll Frederick W

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 881d
  SEC Form 4 filed by Verheyen Patrick

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 881d
  SEC Form 4 filed by Morich Frank

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 1009d
  SEC Form 4: Suri Anish bought $11,040 worth of shares (4,000 units at $2.76), increasing direct ownership by 3% to 135,638 units

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 1022d
  SEC Form 4: Passeri Daniel R bought $8,580 worth of shares (3,000 units at $2.86), increasing direct ownership by 2% to 134,578 units

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 1044d
  SEC Form 4 filed by Levisetti Matteo

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 1044d
  SEC Form 4 filed by Millar Kerri-Ann

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 1044d
  SEC Form 4 filed by Passeri Daniel R

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 1044d
  SEC Form 4 filed by Sandercock Colin

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 1044d
  SEC Form 4 filed by Suri Anish

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 1139d
  SEC Form 4 filed by Garzone Pamela

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 1147d
  SEC Form 4 filed by Verheyen Patrick

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 1164d
  SEC Form 4 filed by Kiener Peter A

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 1197d
  SEC Form 4 filed by Nasshorn Patricia

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 1197d
  SEC Form 4 filed by Suri Anish

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 1197d
  SEC Form 4 filed by Sandercock Colin

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 1197d
  SEC Form 4 filed by Passeri Daniel R

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)

Other CUE categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends